DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Women's Health Homepage

Putting the patient at the center of breast care Insights from Agnes Berzsenyi, president and CEO of GE Healthcare Women’s Health

Beyond detection: How DBT utilization rates impact facility benchmarks New evidence suggests 3D mammo could be as beneficial to providers as it is to patients

Merit Medical Systems closes acquisition of Cianna Medical Deal worth $135 million with possible additional incentivized payments

Remembering Dr. Nancy Cappello A patient advocate and champion of breast density awareness has passed away, but not without leaving her mark on the world

Screenings reduce risk of breast cancer death by 47-60 percent: study New research confirms what most physicians have long believed

Could a new technique make ultrasound interpretation easier? Enhanced contrast, considers intensity and duration of echoes

DBT detects 34 percent more cancers than 2D mammo Increased recall rate should not be a concern, expert says

Are women at low risk undergoing unneeded imaging due to dense breasts? Breast density notification laws may have unintended consequences

Is AI a match for manual interpretation of breast density? Study equates algorithm to experienced mammographer

Etta Pisano American College of Radiology names chief research officer

iCAD's PowerLook Density Assessment
Version 3.4 platform can be used
on GE and Hologic systems

iCAD shares soar following FDA nod for PowerLook Density

by John R. Fischer , Staff Reporter
Shares for iCA Inc. soared last Wednesday in premarket trade following the FDA’s thumbs up for the sale of PowerLook Density Assessment Version 3.4 in the U.S.

The cancer detection and therapy solution enterprise experienced over 30 percent growth upon receiving FDA clearance for its AI intelligence software, which is compatible with its digital breast tomosynthesis platform on GE and Hologic systems.

Story Continues Below Advertisement

Click to visit GE Healthcare Service Shop for ultrasound probe solutions

Get reliable ultrasound probe replacements, faster repair, and service coverage you can count on with GE Healthcare. Service Shop gives customers on-demand access to over 100 OEM new, used, and refurbished probe replacements.

“Version 3.4 now supports assessing density using 2D synthetic images from GE and Hologic systems,” Ken Ferry, CEO of iCAD, told HCB News. “With the updated version, the product can be used for GE and Hologic breast tomosynthesis cases where no 2D FFDM images are acquired.”

Between 40-50 percent of women in the U.S. alone have dense breasts, which pose the risk of increasing the aggressiveness of tumors and masking their presence in mammograms. When used to evaluate dense breast tissue, the sensitivity of mammography decreases from an average of 98 percent to approximately 48 percent.

Using PowerLook Density Assessment Version 3.4 reduces the risk of reader variability, allowing radiologists to more easily determine if a woman may benefit from additional screening by delivering automated, rapid and reproducible assessments of breast density.

The solution utilizes a machine learning technique to categorize a patient’s breast density, based on the American College of Radiology’s Breast Imaging Reporting and Data system (BI-RADS).

While efficient, Ferry says that more action must be taken on the state level to educate patients about breast density and the associated risks, as well as laws in every state that mandate notifying women of their breast density following a mammogram.

“Ideally, patients should be educated about their density and the associated risks, but that's not always the case,” he said. “Many U.S. states require healthcare providers to notify women – typically via a letter. However, not every state has laws in place that require women to receive some level of notification about breast density following a mammogram. We recommend providers be proactive in notifying patients with dense breasts immediately following a screening.”

Stock for iCAD shed 14 percent year to date through Tuesday, while its performance on the S&P 500 SPX rose on Wednesday by 6.9 percent.

Women's Health Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.